PTEN expression is reduced in various tumour types, such as liver, pancreatic, breast and bladder cancers, and is highly involved in regulation of tumour suppressors that downregulate AKT signalling by reducing the output of PI3K at the cell membrane 33, 38, 39. This evidence concerns the gene PTEN and neoplasm.